Management of oromandibular dystonia with botulinum A toxin: a series of cases.
Oromandibular dystonia is a disorder of movement that is often misdiagnosed. We present our experience of six patients treated with botulinum A toxin, for whom we recorded the symptoms, the group of muscles targeted, and the quantity of botulinum toxin used. We used the Glasgow Benefit Inventory (GBI) questionnaire to record and analyse outcomes after treatment. Five of the six patients had a good outcome as recorded by the GBI, the mean (SD) score of which was +40 (28), which reflected that the patients were well satisfied. The overall improvement in the categories of general health, social health, and physical health were 82%, 37%, and 31%, respectively. Botulinum type A toxin is an effective treatment of oromandibular dystonia. It is important for clinicians to recognise the condition, as treatment is well-tolerated and can improve quality of life.
['Teemul|T A|TA|', 'Patel|R|R|', 'Kanatas|A|A|', 'Carter|L M|LM|']
D019274:Botulinum Toxins, Type A D004421:Dystonia D006801:Humans D009465:Neuromuscular Agents D011788:Quality of Life D011795:Surveys and Questionnaires D016896:Treatment Outcome
Oromandibular Dystonia Botulinum A toxin Meige syndrome